Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 25Ovarian function and disordersMagnesium in Health and DiseaseDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

The Effect of Magnesium Supplementation on Insulin Resistance and Metabolic Profiles in Women with Polycystic Ovary Syndrome: a Randomized Clinical Trial

Abstract

Due to the definitive known effect of magnesium on insulin resistance and the fact that insulin resistance is a main etiology in polycystic ovary syndrome (PCOS), it is assumed the use of magnesium supplements can improve insulin resistance, lipid profiles, and glucose and thus may also play a role in improving the clinical condition of patients with PCOS. We aimed to assess the effects of magnesium supplements on anthropometric, clinical, and metabolic parameters in women suffering from PCOS. This triple-blind randomized clinical trial study was conducted on women aged 15-35 years with PCOS. The patients were randomly assigned to receive a magnesium oxide supplement (250 mg/day for 2 months) or a placebo. The study parameters were evaluated and compared between two groups before as well as 2 months and 5 months after the initial assessment. In total, 40 cases (20 in each group) were recruited in the study. A significant reduction in the serum insulin level (P-value = 0.036) and insulin resistance (p-value = 0.032) was observed in the case group. Prescribing magnesium supplements could also lead to lowering total cholesterol, low-density lipoprotein, and fasting blood sugar along with increasing the level of high-density lipoprotein. We could not find any significant difference in anthropometric parameters as well as the mean systolic and diastolic blood pressures before and after intervention between the two groups. Although the rate of oligomenorrhea significantly decreased in the two study groups, it was no different across the two groups before and also after the intervention. The use of magnesium supplements in patients with PCO, regardless of the etiology or progression of the disease, can greatly improve the metabolic status of these patients by improving insulin resistance and modulating the level of lipid profile.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12011-023-03744-7

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 1

  1. Mohammad Alizadeh Charandabi S, Mirghafourvand M, Javadzadeh Y, Nezamivand CS (2014) Effect of calcium with and without magnesium on amount and duration of menstrual bleeding in students with primary dysmenorrhea. Iran J Obstet Gynecol Infertil 16(83):1–8

Cited by

Metadata

Authors
Shahmoradi, S., Chiti, H., Tavakolizadeh, M., Hatami, R., Motamed, N., & Ghaemi, M.
Affiliations
  • Zanjan University of Medical Sciences (IR)
  • Tehran University of Medical Sciences (IR)
Corresponding author
Hatami, Robabeh
Venue
Biological Trace Element Research
Published
2023-07-02
Volume
202
Issue
3
Pages
941-946
ISSN
  • 0163-4984 (ISSN-L)
  • 1559-0720
OpenAlex
W4382793506
Cited by
25
References
21
Citations by year
2026: 7 · 2025: 12 · 2024: 6
FWCI
5.99
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Biological Trace Element Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Nursing › Nutrition and Dietetics › Magnesium in Health and Disease
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
magnesium supplementation, magnesium oxide, polycystic ovary syndrome, insulin resistance, lipid profile, serum insulin, fasting blood glucose, HDL cholesterol, LDL cholesterol, total cholesterol, oligomenorrhea, blood pressure, anthropometric parameters, women
MeSH terms
Adolescent, Adult, Blood Glucose, Double-Blind Method, Female, Humans, Insulin, Insulin Resistance, Lipids, Magnesium, Polycystic Ovary Syndrome, Dietary Supplements, Metabolome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.